Physiologically balanced injectable formulations of fosnetupitant

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11529362
APP PUB NO 20200206249A1
SERIAL NO

16817683

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Injectable dosages and formulations of fosnetupitant and pharmaceutically acceptable salts thereof are provided that are efficacious, chemically stable and physiologically balanced for safety and efficacy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HELSINN HEALTHCARE SA6912 LUGANO-PAZZALLO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cannella, Roberta Varese, IT 39 157
Venturini, Alessio Varese, IT 13 30

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 20, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 20, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 20, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00